Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Read More…
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone978-663-3660
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.90 billion
Profitability
Miscellaneous
Employees6,870
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Bruker (NASDAQ:BRKR) Frequently Asked Questions
What is Bruker's stock symbol?
Bruker trades on the NASDAQ under the ticker symbol "BRKR."
How often does Bruker pay dividends? What is the dividend yield for Bruker?
Bruker announced a quarterly dividend on Monday, August 12th. Shareholders of record on Tuesday, September 3rd will be paid a dividend of $0.04 per share on Friday, September 20th. This represents a $0.16 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Friday, August 30th. View Bruker's Dividend History.
How were Bruker's earnings last quarter?
Bruker Co. (NASDAQ:BRKR) released its quarterly earnings data on Thursday, August, 1st. The medical research company reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.31 by $0.02. The medical research company earned $490.20 million during the quarter, compared to the consensus estimate of $477.70 million. Bruker had a net margin of 9.57% and a return on equity of 27.10%. The company's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.25 EPS. View Bruker's Earnings History.
When is Bruker's next earnings date?
What guidance has Bruker issued on next quarter's earnings?
Bruker issued an update on its FY19 earnings guidance on Thursday, August, 1st. The company provided EPS guidance of $1.57-1.61 for the period, compared to the Thomson Reuters consensus estimate of $1.62. The company issued revenue guidance of $2.028-2.048 billion, compared to the consensus revenue estimate of $2.04 billion.
What price target have analysts set for BRKR?
10 brokerages have issued 1-year price objectives for Bruker's shares. Their predictions range from $43.00 to $57.00. On average, they anticipate Bruker's share price to reach $51.1111 in the next year. This suggests a possible upside of 17.4% from the stock's current price. View Analyst Price Targets for Bruker.
What is the consensus analysts' recommendation for Bruker?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.
Has Bruker been receiving favorable news coverage?
Headlines about BRKR stock have trended somewhat negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bruker earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Bruker.
Are investors shorting Bruker?
Bruker saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 2,475,600 shares, an increase of 44.3% from the July 31st total of 1,715,200 shares. Based on an average daily trading volume, of 932,000 shares, the days-to-cover ratio is presently 2.7 days. Approximately 2.4% of the company's shares are sold short. View Bruker's Current Options Chain.
Who are some of Bruker's key competitors?
Some companies that are related to Bruker include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Avantor (AVTR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
What other stocks do shareholders of Bruker own?
Who are Bruker's key executives?
Bruker's management team includes the folowing people:
- Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
- Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
- Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
- Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
- Dr. Falko Busse, Exec. Officer (Age 52)
Who are Bruker's major shareholders?
Bruker's stock is owned by many different of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (19.20%), Vanguard Group Inc. (6.93%), BlackRock Inc. (3.32%), BlackRock Inc. (3.37%), Acadian Asset Management LLC (2.40%) and Janus Henderson Group PLC (2.13%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.
Which major investors are selling Bruker stock?
BRKR stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Acadian Asset Management LLC, Point72 Asset Management L.P., Marshall Wace North America L.P., BNP Paribas Arbitrage SA, Allianz Asset Management GmbH, Russell Investments Group Ltd. and Man Group plc. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.
Which major investors are buying Bruker stock?
BRKR stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Nuveen Asset Management LLC, APG Asset Management N.V., First Trust Advisors LP, Sector Gamma AS, Price T Rowe Associates Inc. MD, Los Angeles Capital Management & Equity Research Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Bruker.
How do I buy shares of Bruker?
Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Bruker's stock price today?
One share of BRKR stock can currently be purchased for approximately $43.54.
How big of a company is Bruker?
Bruker has a market capitalization of $6.73 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.
What is Bruker's official website?
How can I contact Bruker?
Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]
MarketBeat Community Rating for Bruker (NASDAQ BRKR)
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
